Furthermore, we also report that PEAK1 expression levels significantly and positively correlate with EMT gene expression signatures in patient samples and ER- and/or HER2-positive breast cancer cell populations (S1 Fig). This evidence concerns the gene PEAK1 and breast carcinoma.